DYRK
Los inhibidores de las quinasas DYRK (quinasas reguladas por fosforilación de tirosina de doble especificidad) son compuestos que se dirigen a la familia de quinasas DYRK, involucradas en la regulación del ciclo celular, el desarrollo neuronal y la apoptosis. Las quinasas DYRK tienen doble especificidad, lo que significa que pueden fosforilar residuos de tirosina y serina/treonina. Inhibir las quinasas DYRK puede afectar varios procesos celulares, incluida la progresión del ciclo celular y la diferenciación. Los inhibidores de DYRK son herramientas importantes en la investigación sobre cáncer, enfermedades neurodegenerativas y señalización celular. En CymitQuimica, ofrecemos una selección de inhibidores de DYRK de alta calidad para apoyar su investigación en el control del ciclo celular, neurobiología y desarrollo terapéutico.
Se han encontrado 47 productos para "DYRK".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
JH-XIV-68-3
CAS:JH-XIV-68-3: Selective DYRK1A/B inhibitor; effective in HNSCC cell lines.Fórmula:C21H17F3N8OForma y color:SolidPeso molecular:454.41Dyrk1A-IN-5
CAS:Potent DYRK1A inhibitor with IC50s: 6 nM overall, 0.5 μM SF3B1, 2.1 μM tau phosphorylation. Useful for Down syndrome studies.Fórmula:C16H9IN2O2Forma y color:SolidPeso molecular:388.16AnnH31
CAS:AnnH31 is a potent Dyrk1A inhibitor with an IC50 value of 81 nM.AnnH31 inhibits MAO-A with an IC50 of 3.2 μM.AnnH31 can be used as a probe to confirm theFórmula:C15H13N3OPureza:99.99%Forma y color:Yellow SolidPeso molecular:251.28Dyrk1A-IN-3
CAS:Dyrk1A-IN-3 is a selective DYRK1A inhibitor with an IC50 of 76 nM, useful for neurodegenerative disease research.Fórmula:C18H16N6Forma y color:SolidPeso molecular:316.36tBID
CAS:tBID is a selective homeodomain-interacting protein kinase 2 (HIPK2) inhibitor (IC50 of 0.33 μM)Fórmula:C11H3Br4N3O2Pureza:98%Forma y color:SolidPeso molecular:528.78DYRKi
CAS:DYRKi is a nontoxic, DYRK1-selective inhibitor.Fórmula:C20H13F3N4O2SForma y color:SolidPeso molecular:430.4FINDY
CAS:FINDY selectively inhibits DYRK1A at 35 μM IC50, blocking Ser97 autophosphorylation, useful for neurological disorder research.Fórmula:C16H17NO2S2SiForma y color:SolidPeso molecular:347.53CLK-IN-T3
CAS:CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity.Fórmula:C28H30N6O2Pureza:99.61%Forma y color:SolidPeso molecular:482.58Ref: TM-T14980
1mg47,00€2mg62,00€5mg92,00€10mg160,00€25mg289,00€50mg505,00€100mg787,00€200mg1.063,00€INDY
CAS:INDY is an ATP-competitive inhibitor of Dyrk1A and Dyrk1B with IC50s of 0.24 μM and 0.23 μM and a Ki of 0.18 μM for Dyrk1A ATP pocket, respectively.Fórmula:C12H13NO2SPureza:99.26%Forma y color:Green SolidPeso molecular:235.3YK-2-69
CAS:YK-2-69 selectively blocks DYRK2 at Lys-231 and Lys-234, outperforming enzalutamide in prostate cancer treatment.Fórmula:C25H27FN8OSPureza:98.61% - 99.64%Forma y color:SolidPeso molecular:506.6ARN25068
CAS:ARN25068 inhibits GSK-3β, FYN, DYRK1A kinases; acts in sub-micromolar range; combats tau hyperphosphorylation.Fórmula:C19H18N6SPureza:99.75%Forma y color:SolidPeso molecular:362.45ProINDY
CAS:ProINDY (Pro-indy) is a potent DYRK inhibitor that activates NFAT for the study of Down syndrome.Fórmula:C14H15NO3SPureza:97.19%Forma y color:Yellow SolidPeso molecular:277.34DYRKs-IN-2
CAS:DYRKs-IN-2 has antitumor activity. DYRKs-IN-2 is a potent DYRKs inhibitor with IC50s of 30.6 nM and 12.8 nM for DYRK1B and DYRK1A, respectively.Fórmula:C32H38ClN9O3Pureza:98%Forma y color:SolidPeso molecular:632.16Norharmine
CAS:Norharmine is an analogue of harman and functions as an alkaloid. It serves as an inhibitor of both monoamine oxidase A (MAO-A) and DYRK1A. While it exhibits weak inhibitory activity against MAO-A, it has certain inhibitory effects on DYRK1A.Fórmula:C12H10N2OForma y color:SolidPeso molecular:198.221DYRK1-IN-1
CAS:DYRK1-IN-1: Selective DYRK1A inhibitor with IC50 of 220 nM, good permeability, CNS penetrant for research, no P-glycoprotein issues.Fórmula:C12H12N6Forma y color:SolidPeso molecular:240.26Dyrk1A/α-synuclein-IN-2
Dyrk1A/α-synuclein-IN-2 (Compound b20) is a dual inhibitor of Dyrk1A and α-synuclein aggregation that acts on α-synuclein (IC50: 7.8 μM).Fórmula:C21H16N4O4SForma y color:SolidPeso molecular:420.44DYRKs-IN-1 hydrochloride
CAS:DYRKs-IN-1 HCl inhibits DYRK1A (5 nM IC50) & DYRK1B (8 nM IC50) with antitumor properties.Fórmula:C30H31Cl2N7O4Forma y color:SolidPeso molecular:624.52Dyrk1A-IN-2
Dyrk1A-IN-2 is a DYRK1A inhibitor (EC50: 37 nM). dyrk1A-IN-2 exhibits efficient promotion of human β-cell replication, as well as low cytotoxicity.Fórmula:C27H32N6O4Forma y color:SolidPeso molecular:504.58Dyrk1A-IN-4
CAS:Dyrk1A-IN-4, compound 48, is an oral DYRK1A/DYRK2 inhibitor with IC50s: 2 nM (DYRK1A), 6 nM (DYRK2), anticancer properties.Fórmula:C14H13F3N6Forma y color:SolidPeso molecular:322.29Dyrk1A/α-synuclein-IN-1
Dyrk1A/α-synuclein-IN-1 (Compound b1) is a dual inhibitor of Dyrk1A (IC50: 177 nM) and α-synuclein aggregation (IC50: 10.5 μM).Fórmula:C20H21N5O3SForma y color:SolidPeso molecular:411.48
